MA37531B1 - Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans - Google Patents

Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Info

Publication number
MA37531B1
MA37531B1 MA37531A MA37531A MA37531B1 MA 37531 B1 MA37531 B1 MA 37531B1 MA 37531 A MA37531 A MA 37531A MA 37531 A MA37531 A MA 37531A MA 37531 B1 MA37531 B1 MA 37531B1
Authority
MA
Morocco
Prior art keywords
essential oil
antibacterial effect
actinomycetemcomitans
bitter orange
aaggregatibacter
Prior art date
Application number
MA37531A
Other languages
French (fr)
Other versions
MA37531A1 (en
Inventor
Leila Lakhdar
Abdellah Farah
Oumkeltoum Ennibi
Original Assignee
Université Mohammed V De Rabat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Mohammed V De Rabat filed Critical Université Mohammed V De Rabat
Priority to MA37531A priority Critical patent/MA37531B1/en
Priority to PCT/MA2014/000058 priority patent/WO2016076689A1/en
Publication of MA37531A1 publication Critical patent/MA37531A1/en
Publication of MA37531B1 publication Critical patent/MA37531B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

L’application de l’effet antibactérien de l'huile essentielle de bigaradier (citrus aurantium l.) d'origine marocaine sur une souche bactérienne orale virulente; aggregatibacter actinomycetemcomitans clone jp2. Cette souche originelle n'a jamais fait l’objet de tests, antimicrobiens à base d’huiles essentielles. Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. La technique utilisée est une méthode simple, claire, basée sur la preuve et offrant une meilleure précision et une meilleure reproductibilité des résultats.The application of the antibacterial effect of the essential oil of bitter orange (citrus aurantium l.) Of Moroccan origin on a virulent oral bacterial strain; aggregatibacter actinomycetemcomitans clone jp2. This original strain has never been tested, antimicrobials based on essential oils. This new application encompasses both the methodology and the results obtained. The technique used is a simple, clear, evidence-based method with improved accuracy and reproducibility of results.

MA37531A 2014-11-13 2014-11-13 Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans MA37531B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA37531A MA37531B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
PCT/MA2014/000058 WO2016076689A1 (en) 2014-11-13 2014-12-31 Pharmacological composition of oregano (essential oil) exhibiting an antibacterial effect on the jp2 clone of aggregatibacter actinomycetemcomitans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA37531A MA37531B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Publications (2)

Publication Number Publication Date
MA37531A1 MA37531A1 (en) 2016-06-30
MA37531B1 true MA37531B1 (en) 2017-01-31

Family

ID=52684611

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37531A MA37531B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Country Status (2)

Country Link
MA (1) MA37531B1 (en)
WO (1) WO2016076689A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119169B2 (en) * 2004-12-28 2012-02-21 Colgate-Palmolive Company Oregano oral care compositions and methods of use thereof
EP2663582B1 (en) * 2011-01-13 2018-07-11 Austin Research Labs Corp. High load dispersions for treating infections

Also Published As

Publication number Publication date
WO2016076689A1 (en) 2016-05-19
MA37531A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
CL2020001048A1 (en) Monoclonal antibodies against bcma. (divisional request 201800281)
MA49903A (en) SULPHONYLURIDES AND SULPHONYLTHIOURIDES AS NLRP3 INHIBITORS
CL2019001193A1 (en) Lag-3 binding molecules and methods of using them. (divisional application 201703132).
MA46109A (en) HIGH CONCENTRATE, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS
MA37531B1 (en) Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
AR111099A1 (en) USE OF A SERUM FOR CLOTHING WASHING
BR102019017062A8 (en) TOPICAL COMPOSITIONS INCLUDING PICHIA ANOMALA AND RETINOL
MA37532A1 (en) Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37533A1 (en) Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37534B1 (en) Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37530A1 (en) Pharmacological composition of citronella (essential oil) with antibacterial effect on aggregatibacter actinomycetemcomitans
MA37529A1 (en) Pharmacological composition of pennyroyal mint (essential oil) with antibacterial effect on the aggregatibacter actinomycetemcomitans.
EA201992883A1 (en) ANTIBODIES TO TrkB
BR102019017344A8 (en) TOPICAL COMPOSITIONS COMPRISING PICHIA ANOMALA AND N-ACETYL GLYCOSAMINE
EA202090627A1 (en) METHODS FOR EVALUATING ANTIBODY AND MEDICINE CONJUGATES
BR112016009030A2 (en) apparatus and methods for testing visual function and functional vision at varying luminance levels
MX2019010484A (en) Omega-3 fatty acid and vitamin d levels to identify and attenuate cognitive aging in individuals.
MA49960A (en) HIGH CONCENTRATED, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS OF TREATMENT OF SUBJECTS WITH ATYPICAL HEMOLYTIC SYNDROME
CL2018002949A1 (en) Compositions for oral care.
EA201800413A1 (en) METHOD FOR AUTOMATIC BLOOD VISCOSITY MEASUREMENT
EA201990561A1 (en) COMPOSITIONS CONTAINING ACID EXTRACTS OF MASTIC GUM, AND THEIR APPLICATION FOR TREATMENT OF OPTICAL NEUROPATHY
FR3053891B1 (en) DIFFUSER OF VAPORS, IN PARTICULAR ESSENTIAL OILS
PL409612A1 (en) Method for obtaining new common carrot seeds fragrant oil
BRPI0601730A (en) hair stretching equipment or the like
PL415033A1 (en) Method for analysis of proteins in urine